»
Conference on European Drug Prevention Quality Standards
The conference will also feature two thematic sessions on New Psychoactive Substances (NPS and European legislation on NPS) and harm reduction.
From essential medicine to illicit commodity: new EU report reveals how ketamine diversion is fuelling the illicit market in Europe
Ketamine produced legitimately outside the EU to make medicines is increasingly finding its way onto Europe’s illicit drug...